Spinocerebellar ataxia 28

From WikiMD's WELLNESSPEDIA

Alternate names[edit]

SCA28; Spinocerebellar ataxia type 28

Definition[edit]

Spinocerebellar ataxia 28 (SCA28)is a slowly progressive movement disorder that typically begins in early adulthood (but can affect children and older adults as well).



Cause[edit]

SCA28 is caused by changes in the AFG3L2 gene.

Inheritance[edit]

Autosomal dominant pattern, a 50/50 chance.

Spinocerebellar ataxia type 28 (SCA28) is inherited in an autosomal dominant manner.

Signs and symptoms[edit]

Early signs and symptoms include problems with coordination and balance when walking (gait ataxia), speech and swallowing difficulties (dysarthria), over-reactive reflex reactions in knees and ankles (hyperreflexia), weakness in the muscles that control eye movement (ophthalmoparesis), uncontrolled movement of the eye (nystagmus) and drooping eyelid (ptosis). The symptoms worsen very slowly over time.

For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 80%-99% of people have these symptoms

30%-79% of people have these symptoms

5%-29% of people have these symptoms

1%-4% of people have these symptoms

  • Depressivity(Depression)
  • Head tremor
  • Limb dystonia
  • Memory impairment(Forgetfulness)
  • Rigidity(Muscle rigidity)
  • Spasticity(Involuntary muscle stiffness, contraction, or spasm)

Diagnosis[edit]

Spinocerebellar ataxia type 28 (SCA28) should be suspected in individuals with the following:[1][1].

Establishing the Diagnosis The diagnosis of SCA28 is established in a proband with typical clinical findings and identification of a heterozygous pathogenic variant in AFG3L2 by molecular genetic testing.

Treatment[edit]

At present, only symptomatic treatments are available. These include the following:[2]

  • Crutches (less often canes) and walkers
  • Home adaptations including grab bars for the bathtub or shower chairs and raised toilet seats as needed
  • Physical therapy to ameliorate coordination difficulties, especially with tasks such as eating, dressing, walking, and bathing
  • Stretching exercise for those with pyramidal involvement to avoid contractions and lack of comfort during sleep
  • Speech/language therapy for dysarthria and swallowing difficulties
  • Surgical intervention as needed for severe ptosis

Prevention of Secondary Complications[edit]

Psychological support helps affected individuals cope with the consequences of the disease. Weight control can facilitate ambulation. To avoid complications such as aspiration pneumonia, thickened feeds or gastrostomy should be considered.

References[edit]

  1. Brussino A, Brusco A, Durr A, et al. Spinocerebellar Ataxia Type 28. 2011 May 17 [Updated 2018 Mar 22]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK54582/
  2. Brussino A, Brusco A, Durr A, et al. Spinocerebellar Ataxia Type 28. 2011 May 17 [Updated 2018 Mar 22]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK54582/





NIH genetic and rare disease info[edit]

Spinocerebellar ataxia 28 is a rare disease.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.